These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 1645517)

  • 21. Neuroreceptor mapping with in-vivo imaging techniques: principles and applications.
    Busatto GF; Pilowsky LS
    Br J Hosp Med; 1995 Apr 5-18; 53(7):309-13. PubMed ID: 7788065
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Imaging of delta- and mu-opioid receptors in temporal lobe epilepsy by positron emission tomography.
    Madar I; Lesser RP; Krauss G; Zubieta JK; Lever JR; Kinter CM; Ravert HT; Musachio JL; Mathews WB; Dannals RF; Frost JJ
    Ann Neurol; 1997 Mar; 41(3):358-67. PubMed ID: 9066357
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Investigation of the opioid system in absence seizures with positron emission tomography.
    Bartenstein PA; Duncan JS; Prevett MC; Cunningham VJ; Fish DR; Jones AK; Luthra SK; Sawle GV; Brooks DJ
    J Neurol Neurosurg Psychiatry; 1993 Dec; 56(12):1295-302. PubMed ID: 8270930
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vivo distribution of opioid receptors in man in relation to the cortical projections of the medial and lateral pain systems measured with positron emission tomography.
    Jones AK; Qi LY; Fujirawa T; Luthra SK; Ashburner J; Bloomfield P; Cunningham VJ; Itoh M; Fukuda H; Jones T
    Neurosci Lett; 1991 May; 126(1):25-8. PubMed ID: 1650933
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endogenous opiate response to pain in rheumatoid arthritis and cortical and subcortical response to pain in normal volunteers using positron emission tomography.
    Jones AK; Liyi Q; Cunningham VV; Brown DW; Ha-Kawa S; Fujiwara T; Friston KF; Silva S; Luthra SK; Jones T
    Int J Clin Pharmacol Res; 1991; 11(6):261-6. PubMed ID: 1668382
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multicompartmental analysis of [11C]-carfentanil binding to opiate receptors in humans measured by positron emission tomography.
    Frost JJ; Douglass KH; Mayberg HS; Dannals RF; Links JM; Wilson AA; Ravert HT; Crozier WC; Wagner HN
    J Cereb Blood Flow Metab; 1989 Jun; 9(3):398-409. PubMed ID: 2541148
    [TBL] [Abstract][Full Text] [Related]  

  • 27. individual variation in sleep quality and duration is related to cerebral mu opioid receptor binding potential during tonic laboratory pain in healthy subjects.
    Campbell CM; Bounds SC; Kuwabara H; Edwards RR; Campbell JN; Haythornthwaite JA; Smith MT
    Pain Med; 2013 Dec; 14(12):1882-92. PubMed ID: 24102962
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Non-invasive methods to study drug disposition: positron emission tomography. Detection and quantification of brain receptors in man.
    Sadzot B; Franck G
    Eur J Drug Metab Pharmacokinet; 1990; 15(2):135-42. PubMed ID: 2166673
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mu-opiate receptors measured by positron emission tomography are increased in temporal lobe epilepsy.
    Frost JJ; Mayberg HS; Fisher RS; Douglass KH; Dannals RF; Links JM; Wilson AA; Ravert HT; Rosenbaum AE; Snyder SH
    Ann Neurol; 1988 Mar; 23(3):231-7. PubMed ID: 2837132
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantification of opiate receptors in two patients with mesiobasal temporal lobe epilepsy, before and after selective amygdalohippocampectomy, using positron emission tomography.
    Bartenstein PA; Prevett MC; Duncan JS; Hajek M; Wieser HG
    Epilepsy Res; 1994 Jun; 18(2):119-25. PubMed ID: 7957034
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Opioid imaging.
    Hammers A; Lingford-Hughes A
    Neuroimaging Clin N Am; 2006 Nov; 16(4):529-52, vii. PubMed ID: 17148018
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vivo imaging of neurotransmitter systems using radiolabeled receptor ligands.
    Kegeles LS; Mann JJ
    Neuropsychopharmacology; 1997 Nov; 17(5):293-307. PubMed ID: 9348545
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preparation and biodistribution in mice of [11C]carfentanil: a radiopharmaceutical for studying brain mu-opioid receptors by positron emission tomography.
    Saji H; Tsutsumi D; Magata Y; Iida Y; Konishi J; Yokoyama A
    Ann Nucl Med; 1992 Feb; 6(1):63-7. PubMed ID: 1325823
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Imaging opiate receptors in the human brain by positron tomography.
    Frost JJ; Wagner HN; Dannals RF; Ravert HT; Links JM; Wilson AA; Burns HD; Wong DF; McPherson RW; Rosenbaum AE
    J Comput Assist Tomogr; 1985; 9(2):231-6. PubMed ID: 2982931
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Functional imaging in mental disorders].
    Borbély K
    Orv Hetil; 2004 Feb; 145(6):277-89. PubMed ID: 15038321
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Imaging of receptors in clinical neurosciences.
    Korf J
    Acta Neurol Belg; 1997 Sep; 97(3):200-5. PubMed ID: 9345594
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Positron emission tomography studies of brain receptors.
    Mazière B; Mazière M
    Fundam Clin Pharmacol; 1991; 5(1):61-91. PubMed ID: 1676695
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PET study of D(1) dopamine receptor binding in neuroleptic-naive patients with schizophrenia.
    Karlsson P; Farde L; Halldin C; Sedvall G
    Am J Psychiatry; 2002 May; 159(5):761-7. PubMed ID: 11986129
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Positron emission tomography: basic principles and applications in psychiatric research.
    Volkow ND; Brodie J; Bendriem B
    Ann N Y Acad Sci; 1991; 620():128-44. PubMed ID: 2035939
    [No Abstract]   [Full Text] [Related]  

  • 40. [The use of positron-emission tomography in psychiatry].
    Vlad T; Stanciu J
    Rev Med Chir Soc Med Nat Iasi; 1990; 94(1):95-7. PubMed ID: 1981625
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.